140 related articles for article (PubMed ID: 6606219)
21. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
22. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
23. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
24. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
Erhardt CC; Mumford P; Maini RN
Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
[TBL] [Abstract][Full Text] [Related]
25. Porcine C1q and the solid-phase immunoassay of human immune complexes.
Ziola B; Salmi A; Penttinen K
J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
[TBL] [Abstract][Full Text] [Related]
26. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
[TBL] [Abstract][Full Text] [Related]
27. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
28. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
29. The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.
Faaber P; Capel PJ; Koene RA
Clin Exp Immunol; 1981 Sep; 45(3):590-4. PubMed ID: 6978209
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
[TBL] [Abstract][Full Text] [Related]
31. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
Bratt T; Ohlson S
J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
[TBL] [Abstract][Full Text] [Related]
32. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
Jacobs RJ; Mocharla R
J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
[TBL] [Abstract][Full Text] [Related]
33. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
Kilpatrick JM; Virella G
Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
[TBL] [Abstract][Full Text] [Related]
34. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
Levinson SS; Goldman JO
J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
[TBL] [Abstract][Full Text] [Related]
36. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
38. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
39. [The liquid phase C1q binding assay and its clinical application].
Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
[No Abstract] [Full Text] [Related]
40. C1q binding and C1q deviation assays using enzyme labelled C1q.
Smith GW; Myles MJ; Simpson IJ
J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]